Biorelevant in-vitro performance testing of orally administered dosage forms.
about
Analytical technologies for real-time drug dissolution and precipitation testing on a small scale.Microencapsulation of Lactobacillus acidophilus NCIMB 701748 in matrices containing soluble fibre by spray drying: Technological characterization, storage stability and survival after in vitro digestion.Probiotic edible films as a new strategy for developing functional bakery products: The case of pan bread.Dual Level Statistical Investigation of Equilibrium Solubility in Simulated Fasted and Fed Intestinal Fluid.Two Phase 1, Open-Label, Single-Dose, Randomized, Crossover Studies to Assess the Pharmacokinetics, Safety, and Tolerability of Orally Administered Granules of Secnidazole (2 g) in Healthy Female Volunteers Under Different Administration Conditions.Biorelevant in vitro performance testing of orally administered dosage forms-workshop report.Use of biorelevant media for assessment of a poorly soluble weakly basic drug in the form of liquisolid compacts: in vitro and in vivo study.
P2860
Q38212289-5495D690-75CA-4F4E-BF52-1484D29BE629Q38789643-12AA24DF-8BD6-489F-AA1A-057CA4FEB262Q39149007-433C5AAF-0AF6-4009-B966-BB6C8AFC286EQ47145238-654CF69A-7CEE-4A5F-9904-1094620BECA5Q47583539-C8D7B03F-6CE7-4D63-96E6-3E90281B66C2Q51242125-D2F9AD11-147D-4027-B87B-5C63B5EAE7A4Q53841389-1A9DE3FA-4A60-4480-9E2E-67BC1C7E5B21
P2860
Biorelevant in-vitro performance testing of orally administered dosage forms.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Biorelevant in-vitro performance testing of orally administered dosage forms.
@en
type
label
Biorelevant in-vitro performance testing of orally administered dosage forms.
@en
prefLabel
Biorelevant in-vitro performance testing of orally administered dosage forms.
@en
P2860
P1476
Biorelevant in-vitro performance testing of orally administered dosage forms.
@en
P2093
Christos Reppas
Maria Vertzoni
P2860
P304
P356
10.1111/J.2042-7158.2012.01474.X
P577
2012-03-27T00:00:00Z